Tissue-Engineered Vascular Grafts: Autologous Off-the-Shelf Vascular Access?

Seminars in Nephrology

Volumn 32, Issue 6, 2012, Pages 582-591

  Manson, Roberto J ^a   Unger, Joshua M ^a   Ali, Aamna ^b   Gage, Shawn M ^a   Lawson, Jeffrey H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic; Arteriovenous access; Arteriovenous graft; Autologous; Tissue engineering; Tissue engineered graft; Vascular graft; Xenogenic

Indexed keywords

ARTERIOVENOUS FISTULA; ARTICLE; BIOREACTOR; BLOOD VESSEL GRAFT; CANNULATION; DIALYSIS; HEMODIALYSIS; HUMAN; IN VIVO STUDY; INFECTION RATE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TISSUE ENGINEERING; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; HUMANS; RENAL DIALYSIS; TRANSPLANTATION, AUTOLOGOUS; VASCULAR ACCESS DEVICES; VASCULAR GRAFTING;

EID: 84870664098     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2012.10.010     Document Type: Article

References (54)

1. Scribner B.H., Caner J.E., Buri R., Quinton W. The technique of continous hemodialysis. Trans Am Soc Artif Intern Organs 1960, 6:88-103.
2. Brescia M.J., Cimino J.E., Appel K., Hurwich B.J. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966, 275:1089-1092.
3. Flores Izquierdo G., Ronces Vivero R., Exaire E., Hernandez Chavez A., Gomez de los Rios J. [Venous autologous graft for hemodialysis (original technic). Preliminary report]. Arch Inst Cardiol Mex 1969, 39:259-266.
4. May J., Tiller D., Johnson J., Stewart J., Sheil A.G. Saphenous-vein arteriovenous fistula in regular dialysis treatment. N Engl J Med 1969, 280:770.
5. Johnson J.M., Goldfarb D., Baker L.D. Expanded polytetrafluoroethylene as a small artery replacement. A preliminary report. Am J Surg 1976, 132:723-727.
6. Dixon B.S., Beck G.J., Vazquez M.A., Greenberg A., Delmez J.A., Allon M., et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 2009, 360:2191-2201.
7. Huber T.S., Carter J.W., Carter R.L., Seeger J.M. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg 2003, 38:1005-1011.
8. Keuter X.H., De Smet A.A., Kessels A.G., van der Sande F.M., Welten R.J., Tordoir J.H. A randomized multicenter study of the outcome of brachial-basilic arteriovenous fistula and prosthetic brachial-antecubital forearm loop as vascular access for hemodialysis. J Vasc Surg 2008, 47:395-401.
9. Sidawy A.N., Gray R., Besarab A., Henry M., Ascher E., Silva M., et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2002, 35:603-610.
10. National Kidney Foundation KDOQI clinical practice guidelines for vascular access. Guideline 7: prevention and treatment of catheter and port complications 2006, Vol 1:S248-S257. Vascular Access Work Group Supplement, New York.
11. Ahluwalia H.S., Gage S.M., Lawson J.H. Vascular access. Clinical review of vascular surgery 2010, 265-292. Catalyst Publishers, Durham. S.S. Desai, C.K. Shortel (Eds.).
12. Isenberg B.C., Williams C., Tranquillo R.T. Small-diameter artificial arteries engineered in vitro. Circ Res 2006, 98:25-35.
13. Weinberg C.B., Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231:397-400.
14. Girton T.S., Oegema T.R., Grassl E.D., Isenberg B.C., Tranquillo R.T. Mechanisms of stiffening and strengthening in media-equivalents fabricated using glycation. J Biomech Eng 2000, 122:216-223.
15. Cummings C.L., Gawlitta D., Nerem R.M., Stegemann J.P. Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 2004, 25:3699-3706.
16. Deutsch M., Meinhart J., Vesely M., Fischlein T., Groscurth P., von Oppell U., et al. In vitro endothelialization of expanded polytetrafluoroethylene grafts: a clinical case report after 41 months of implantation. J Vasc Surg 1997, 25:757-763.
17. Aper T., Schmidt A., Duchrow M., Bruch H.P. Autologous blood vessels engineered from peripheral blood sample. Eur J Vasc Endovasc Surg 2007, 33:33-39.
18. L'Heureux N., Dusserre N., Marini A., Garrido S., de la Fuente L., McAllister T. Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat Clin Pract Cardiovasc Med 2007, 4:389-395.
19. Dahl S.L., Koh J., Prabhakar V., Niklason L.E. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 2003, 12:659-666.
20. Rosenberg N., Martinez A., Sawyer P.N., Wesolowski S.A., Postlethwait R.W., Dillon M.L. Tanned collagen arterial prosthesis of bovine carotid origin in man. Preliminary studies of enzyme-treated heterografts. Ann Surg 1966, 164:247-256.
21. Hutchin P., Jacobs J.R., Devin J.B., Shaughnessy S., Roland A.S. Bovine graft arteriovenous fistulas for maintenance hemodialysis. Surg Gynecol Obstet 1975, 141:255-258.
22. Kaplan M.S., Mirahmadi K.S., Winer R.L., Gorman J.T., Dabirvaziri N., Rosen S.M. Comparison of "PTFE" and bovine grafts for blood access in dialysis patients. Trans Am Soc Artif Intern Organs 1976, 22:388-393.
23. Dale W.A., Lewis M.R. Further experiences with bovine arterial grafts. Surgery 1976, 80:711-721.
24. Hatzibaloglou A., Velissaris I., Kaitzis D., Grekas D., Avdelidou A., Kiskinis D. ProCol vascular bioprosthesis for vascular access: midterm results. J Vasc Access 2004, 5:16-18.
25. Matsuura J.H., Rosenthal D., Wellons E.D., Castronovo C.S., Fronk D. Hemodialysis graft infections treated with cryopreserved femoral vein. Cardiovasc Surg 2002, 10:561-565.
26. Lin P.H., Brinkman W.T., Terramani T.T., Lumsden A.B. Management of infected hemodialysis access grafts using cryopreserved human vein allografts. Am J Surg 2002, 184:31-36.
27. Bolton W.D., Cull D.L., Taylor S.M., Carsten C.G., Snyder B.A., Sullivan T.M., et al. The use of cryopreserved femoral vein grafts for hemodialysis access in patients at high risk for infection: a word of caution. J Vasc Surg 2002, 36:464-468.
28. Madden R.L., Lipkowitz G.S., Browne B.J., Kurbanov A. Experience with cryopreserved cadaveric femoral vein allografts used for hemodialysis access. Ann Vasc Surg 2004, 18:453-458.
29. Madden R., Lipkowitz G., Benedetto B., Kurbanov A., Miller M., Bow L. Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation. Am J Kidney Dis 2002, 40:1240-1243.
30. Sparks C.H. Autogenous grafts made to order. Ann Thorac Surg 1969, 8:104-113.
31. Sparks C.H. Silicone mandril method for growing reinforced autogenous femoro-popliteal artery grafts in situ. Ann Surg 1973, 177:293-300.
32. Hallin R.W. Complications with the mandril-grown (Sparks) dacron arterial graft. Am Surg 1975, 41:550-554.
33. Campbell J.H., Efendy J.L., Campbell G.R. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res 1999, 85:1173-1178.
34. Chue W.L., Campbell G.R., Caplice N., Muhammed A., Berry C.L., Thomas A.C., et al. Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts. J Vasc Surg 2004, 39:859-867.
35. Edwards G.A., Roberts G. Development of an ovine collagen-based composite biosynthetic vascular prosthesis. Clin Mater 1992, 9:211-223.
36. Enzler M.A., Rajmon T., Lachat M., Largiader F. Long-term function of vascular access for hemodialysis. Clin Transplant 1996, 10:511-515.
37. Palumbo R., Niscola P., Calabria S., Fierimonte S., Bevilacqua M., Scaramucci L., et al. Long-term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis. Nephron Clin Pract 2009, 113:c76-c80.
38. Shin'oka T., Imai Y., Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001, 344:532-533.
39. Weiler A., Helling H.J., Kirch U., Zirbes T.K., Rehm K.E. Foreign-body reaction and the course of osteolysis after polyglycolide implants for fracture fixation: experimental study in sheep. J Bone Joint Surg Br 1996, 78:369-376.
40. Dahl S.L., Kypson A.P., Lawson J.H., Blum J.L., Strader J.T., Li Y., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011, 3:68ra69.
41. Peck M.K., Dusserre N., Zagalski K., Garrido S.A., Wystrychowski W., Glickman M.H., et al. New biological solutions for hemodialysis access. J Vasc Access 2011, 12:185-192.
42. Konig G., McAllister T.N., Dusserre N., Garrido S.A., Iyican C., Marini A., et al. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 2009, 30:1542-1550.
43. Wystrychowski W., Cierpka L., Zagalski K., Garrido S., Dusserre N., Radochonski S., et al. Case study: first implantation of a frozen, devitalized tissue-engineered vascular graft for urgent hemodialysis access. J Vasc Access 2011, 12:67-70.
44. Schmitz-Rixen T., Megerman J., Anderson J.M., Warnock D.F., L'Italien G.J., Erasmi H., et al. Longterm study of a compliant biological vascular graft. Eur J Vasc Surg 1991, 5:149-158.
45. Sill T.J., von Recum H.A. Electrospinning: applications in drug delivery and tissue engineering. Biomaterials 2008, 29:1989-2006.
46. Poh M., Boyer M., Solan A., Dahl S.L., Pedrotty D., Banik S.S., et al. Blood vessels engineered from human cells. Lancet 2005, 365:2122-2124.
47. Hoenig M.R., Campbell G.R., Rolfe B.E., Campbell J.H. Tissue-engineered blood vessels: alternative to autologous grafts?. Arterioscler Thromb Vasc Biol 2005, 25:1128-1134.
48. Katzman H.E., Schild A.F., Vanderwerf B.A. Bovine artegraft arteriovenous fistulas for hemodialysis in one-hundred patients after "conventional" arteriovenous fistulas failed. Vasc Surg 1976, 10:169-175.
49. Kennealey P.T., Elias N., Hertl M., Ko D.S., Saidi R.F., Markmann J.F., et al. A prospective, randomized comparison of bovine carotid artery and expanded polytetrafluoroethylene for permanent hemodialysis vascular access. J Vasc Surg 2011, 53:1640-1648.
50. Katzman H.E., Glickman M.H., Schild A.F., Fujitani R.M., Lawson J.H. Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. J Am Coll Surg 2005, 201:223-230.
51. Werkmeister J.A., White J.F., Ramshaw J.A. Evaluation of the Omniflow collagen-polymer vascular prosthesis. Med Prog Technol 1994, 20:231-242.
52. Wang S.S., Chu S.H. Clinical use of omniflow vascular graft as arteriovenous bridging graft for hemodialysis. Artif Organs 1996, 20:1278-1281.
53. McAllister T.N., Maruszewski M., Garrido S.A., Wystrychowski W., Dusserre N., Marini A., et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009, 373:1440-1446.
54. McAllister T. First human use of an allogeneic tissue engineered vascular graft. Circulation 2011, 124:659-660.